{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06419374",
            "orgStudyIdInfo": {
                "id": "BIO89-100-132"
            },
            "organization": {
                "fullName": "89bio, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH",
            "officialTitle": "A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ENLIGHTEN-Cirrhosis)",
            "therapeuticArea": [
                "Gastroenterology"
            ],
            "study": "a-study-to-evaluate-the-efficacy-and-safety-of-pegozafermin-in-participants-with-compensated-cirrhosis-due-to-mash"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2031-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-05-14",
            "studyFirstSubmitQcDate": "2024-05-14",
            "studyFirstPostDateStruct": {
                "date": "2024-05-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "89bio, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The study will assess the efficacy and safety of pegozafermin administered in participants with compensated cirrhosis due to MASH (biopsy-confirmed fibrosis stage F4 MASH \\[previously known as nonalcoholic steatohepatitis, NASH\\])."
        },
        "conditionsModule": {
            "conditions": [
                "Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis"
            ],
            "keywords": [
                "Liver disease",
                "Fatty Liver",
                "Digestive System Diseases",
                "Metabolic diseases",
                "Metabolic Dysfunction-Associated Steatohepatitis",
                "MASH",
                "Nonalcoholic steatohepatitis",
                "NASH",
                "Metabolic dysfunction-associated steatotic liver disease",
                "MASLD",
                "Nonalcoholic fatty liver disease",
                "NAFLD",
                "Fibrosis",
                "Cirrhosis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 762,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Pegozafermin",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Biological: Pegozafermin"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Matched placebo",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "Pegozafermin",
                    "description": "Subcutaneous injection",
                    "armGroupLabels": [
                        "Pegozafermin"
                    ],
                    "otherNames": [
                        "BIO89-100"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Subcutaneous injection",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Proportion of Participants Achieving Fibrosis Regression",
                    "description": "Fibrosis regression is defined as improvement in fibrosis by \u22651 stage, at Month 24 biopsy relative to baseline biopsy.",
                    "timeFrame": "Baseline through Month 24"
                },
                {
                    "measure": "Time to First Occurrence of Disease Progression as Measured by Composite of Protocol -Specified Clinical Events",
                    "timeFrame": "Baseline through Month 60"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change from Baseline in Enhanced Liver Fibrosis (ELF) Score",
                    "timeFrame": "Baseline, Month 24 and Month 60"
                },
                {
                    "measure": "Change from Baseline in Alanine Aminotransferase (ALT) Level",
                    "timeFrame": "Baseline, Month 24 and Month 60"
                },
                {
                    "measure": "Change from Baseline in FibroScan Vibration-controlled Transient Elastography (VCTE)",
                    "timeFrame": "Baseline, Month 24 and Month 60"
                },
                {
                    "measure": "Proportion of Participants who Develop Clinically Significant Portal Hypertension (CSPH)",
                    "timeFrame": "Baseline through Month 60"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Males or non-pregnant females aged between 18 and 75 years (inclusive) at time of signing the informed consent form (ICF).\n* At least 1 metabolic risk factor.\n* Biopsy-confirmed fibrosis stage F4 MASH (per non-alcoholic steatohepatitis \\[NASH\\] Clinical Research Network (CRN) system) with compensated cirrhosis.\n* Body mass index (BMI) at screening \u226525.0 (\u226523.0 for Asian participants) and \\<50.0 kilograms (kg)/meters squared (m\\^2).\n\nKey Exclusion Criteria:\n\n* Liver disorder other than MASH.\n* History or evidence of hepatic decompensation.\n* History or evidence of hepatocellular carcinoma.\n* Have type 1 diabetes mellitus or poorly controlled type 2 diabetes mellitus.\n* ALT or aspartate aminotransferase (AST) \u2265250 units per liter (U/L).\n* Participants taking vitamin E (\\>400 international units \\[IU\\]/day) must be on stable dose for at least 6 months prior to screening.\n\nOther inclusion and exclusion criteria may apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "75 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "ENLIGHTEN clinical trial",
                    "role": "CONTACT",
                    "phone": "1-415-432-9270",
                    "email": "enlighten@89bio.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Maya Margalit, MD",
                    "affiliation": "89bio, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "89bio Clinical Study Site",
                    "status": "RECRUITING",
                    "city": "Homewood",
                    "state": "Alabama",
                    "zip": "35209",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "89bio Clinical Study Site",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.47177,
                        "lon": -86.80082
                    }
                },
                {
                    "facility": "89bio Clinical Study Site",
                    "status": "RECRUITING",
                    "city": "Rialto",
                    "state": "California",
                    "zip": "92377",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "89bio Clinical Study Site",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.1064,
                        "lon": -117.37032
                    }
                },
                {
                    "facility": "89bio Clinical Study Site",
                    "status": "RECRUITING",
                    "city": "Lady Lake",
                    "state": "Florida",
                    "zip": "32159",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "89bio Clinical Study Site",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.91749,
                        "lon": -81.92286
                    }
                },
                {
                    "facility": "89bio Clinical Study Site",
                    "status": "RECRUITING",
                    "city": "New Port Richey",
                    "state": "Florida",
                    "zip": "34653",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "89bio Clinical Study Site",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.24418,
                        "lon": -82.71927
                    }
                },
                {
                    "facility": "89bio Clinical Study Site",
                    "status": "RECRUITING",
                    "city": "Ocala",
                    "state": "Florida",
                    "zip": "34471",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "89bio Clinical Study Site",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.1872,
                        "lon": -82.14009
                    }
                },
                {
                    "facility": "89bio Clinical Study Site",
                    "status": "RECRUITING",
                    "city": "Florham Park",
                    "state": "New Jersey",
                    "zip": "07932",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "89bio Clinical Study Site",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.78788,
                        "lon": -74.38821
                    }
                },
                {
                    "facility": "89bio Clinical Study Site",
                    "status": "RECRUITING",
                    "city": "Dayton",
                    "state": "Ohio",
                    "zip": "45414",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "89bio Clinical Study Site",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.75895,
                        "lon": -84.19161
                    }
                },
                {
                    "facility": "89bio Clinical Study Site",
                    "status": "RECRUITING",
                    "city": "Hermitage",
                    "state": "Tennessee",
                    "zip": "37076",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "89bio Clinical Study Site",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.19617,
                        "lon": -86.6225
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008103",
                    "term": "Liver Cirrhosis"
                },
                {
                    "id": "D000005234",
                    "term": "Fatty Liver"
                },
                {
                    "id": "D000065626",
                    "term": "Non-alcoholic Fatty Liver Disease"
                },
                {
                    "id": "D000005355",
                    "term": "Fibrosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000008107",
                    "term": "Liver Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M8485",
                    "name": "Fibrosis",
                    "asFound": "Cirrhosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8375",
                    "name": "Fatty Liver",
                    "asFound": "Steatohepatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30540",
                    "name": "Non-alcoholic Fatty Liver Disease",
                    "asFound": "Nonalcoholic Steatohepatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11107",
                    "name": "Liver Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11103",
                    "name": "Liver Cirrhosis",
                    "asFound": "Cirrhosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5868",
                    "name": "Visceral Steatosis",
                    "asFound": "Steatohepatitis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M11110",
                    "name": "Liver Extracts",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}